Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) × tusamitamab ravtansine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1 Non-squamous Non-small Cell Lung Cancer 1 Non-small Cell Lung Cancer Metastatic 1 Lung Neoplasms 1 Breast Neoplasms 1 Breast Cancer Metastatic 1 Adenocarcinoma Gastric 1

Interventions

tusamitamab ravtansine 1 pembrolizumab 1 Pemetrexed 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04524689 2025-10-29

CARMEN-LC05

Sanofi

Phase 2 Terminated

57 enrolled 26 charts

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡